Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials

Dyslipidemia is one of the most common adverse effects in schizophrenia patients treated with antipsychotics. However, there are no established effective treatments. In this study, data were pooled from two randomized, placebo-controlled trials, which were originally designed to examine the efficacy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Psychiatry
Principais autores: Wu, R-R, Zhang, F-Y, Gao, K-M, Ou, J-J, Shao, P, Jin, H, Guo, W-B, Chan, P K, Zhao, J-P
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5078852/
https://ncbi.nlm.nih.gov/pubmed/26809842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mp.2015.221
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados